Understanding how harmful chemicals affect lung health using advanced technology.

Characterizing chemical threat agent exposures using a lung-on-a-chip platform and multi-omic analysis of common pathophysiological mechanisms

['FUNDING_R01'] · WAKE FOREST UNIVERSITY HEALTH SCIENCES · NIH-10913409

This study is looking at how harmful chemicals affect lung health using a special 3D model that acts like human lungs, with the goal of finding better ways to protect and treat people who have lung injuries from these substances.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorWAKE FOREST UNIVERSITY HEALTH SCIENCES (nih funded)
Locations1 site (WINSTON-SALEM, UNITED STATES)
Trial IDNIH-10913409 on ClinicalTrials.gov

What this research studies

This research investigates the effects of highly toxic chemicals on lung health by utilizing a 3D lung model that mimics human airway tissues. The team will expose these models to various harmful substances to observe how they cause injury and to identify potential treatments. By analyzing the biological responses at a molecular level, the research aims to uncover new pathways of toxicity and develop medical countermeasures to protect against these threats. Patients may benefit from improved understanding and treatment options for lung injuries caused by chemical exposures.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who have been exposed to harmful chemicals or are at risk of such exposures, particularly those in high-risk occupations or environments.

Not a fit: Patients who have not been exposed to any toxic chemicals or who do not have lung-related health issues may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better prevention and treatment strategies for lung injuries caused by toxic chemical exposures.

How similar studies have performed: Other research has shown promise in using similar 3D lung models to study toxic exposures, indicating that this approach could yield valuable insights.

Where this research is happening

WINSTON-SALEM, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.